Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) currently has a daily average trading volume of 2.11M but it saw 1351275 shares traded in last market. With a market cap of 1.25B USD, the company’s current market price of $4.94 came rising about 3.56 while comparing to the previous closing price of $4.77. In past 52 weeks, the stock remained buoying in the range of price level as high as $11.56 and as low as $4.28. In the recent trading on the day, stock has struck highest price mark of $4.76 while lowest mark touched by it was $5.02.
Taking a look at 20-day trading activity of Maravai LifeSciences Holdings Inc (MRVI) gives us an average price of $5.15, while its current price level is -57.25% below from 52-week high level whereas it is 15.56% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $5.36 while that of 200 days or SMA-200 reads an average of $7.57. A closer look into the stock’s movement over the week reveals that its volatility is standing at 6.28% during that period while stretching the period over a month that increases to 8.95%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 43.73 which implies that the stock is in neutral territory.
Goldman downgraded its recommendation for the stock as a “Sell” from “Neutral” on December 05, 2024 while assigning a price target of $4.25.
Over the week, MRVI’s stock price is moving -1.79% down while it is -13.03% when we observe its performance for the past one month. Year-to-date it is -9.36% down and over the past year, the stock is showing a downside performance of -5.73%.
Currently, Maravai LifeSciences Holdings Inc’s total number of outstanding shares is 141.59M. Company’s return on investment (ROI) stands at -25.16% and return on equity (ROE) at -51.98%. Stock’s beta reads -0.08. Stock has a price to book (P/B) ratio of 2.03 while price to sale or P/S ratio amounts to 4.50. Its return on asset (ROA) is -12.67% on average.
